Depression and Cardiovascular Disease

被引:33
作者
Glassman, A. [1 ]
机构
[1] Columbia Univ, Dept Psychiat, Coll Phys & Surg 14, New York, NY 10032 USA
关键词
D O I
10.1055/s-2008-1058108
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This manuscript reviews the evidence that depression is associated with increased risk of mortality and explores the evidence that treating depression reduces that risk. The thought that depression and death are linked is ancient, but scientifically it has been difficult to prove. After the World War 11, type "A" personality appeared capable of identifying cardiac patients at increased risk of death. By the mid 1970s that evidence appeared to weaken and may have been altered by the changing treatment of cardiovascular disease. At the same time, research began to focus on a diagnosis of depression as a predictor but it was 25 years before the association was firmly established. Originally examined in medically healthy individuals followed for long periods of time, in the early 1990s epidemiological research began examining the influence of depression in patients with overt cardiovascular disease. That focus has been primarily on post-MI depression and the obvious question was if treating depression would reduce the risk. Such studies require a very large sample and initially there was no safety data available with any antidepressant drug. Gradually evidence has accumulated that SSRI antidepressants were safe and effective and there is a suggestion that they reduce not only depression but medical adverse events as well. However, that evidence is not definitive and the reason behind the association between depression and cardiovascular morbidity and mortality remains uncertain.
引用
收藏
页码:221 / 225
页数:5
相关论文
共 44 条
[1]   Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: Clinical implications [J].
Alesci, S ;
Martinez, PE ;
Kelkar, S ;
Ilias, I ;
Ronsaville, DS ;
Listwak, SJ ;
Ayala, AR ;
Licinio, J ;
Gold, HK ;
Kling, MA ;
Chrousos, GP ;
Gold, PW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) :2522-2530
[2]   DEPRESSED AFFECT, HOPELESSNESS, AND THE RISK OF ISCHEMIC-HEART-DISEASE IN A COHORT OF UNITED-STATES ADULTS [J].
ANDA, R ;
WILLIAMSON, D ;
JONES, D ;
MACERA, C ;
EAKER, E ;
GLASSMAN, A ;
MARKS, J .
EPIDEMIOLOGY, 1993, 4 (04) :285-293
[3]  
Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106
[4]  
Bush D E, 2005, Evid Rep Technol Assess (Summ), P1
[5]   Even minimal symptoms of depression increase mortality risk after acute myocardial infarction [J].
Bush, DE ;
Ziegelstein, RC ;
Tayback, M ;
Richter, D ;
Stevens, S ;
Zahalsky, H ;
Fauerbach, JA .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (04) :337-341
[6]   Depression, the autonomic nervous system, and coronary heart disease [J].
Carney, RM ;
Freedland, KE ;
Veith, RC .
PSYCHOSOMATIC MEDICINE, 2005, 67 :S29-S33
[7]   Depression, heart rate variability, and acute myocardial infarction [J].
Carney, RM ;
Blumenthal, JA ;
Stein, PK ;
Watkins, L ;
Catellier, D ;
Berkman, LF ;
Czajkowski, SM ;
O'Connor, C ;
Stone, PH ;
Freedland, KE .
CIRCULATION, 2001, 104 (17) :2024-2028
[8]   Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study [J].
Connerney, I ;
Shapiro, PA ;
McLaughlin, JS ;
Bagiella, E ;
Sloan, RP .
LANCET, 2001, 358 (9295) :1766-1771
[9]   Depressive symptoms and increased risk of stroke mortality over a 29-year period [J].
Everson, SA ;
Roberts, RE ;
Goldberg, DE ;
Kaplan, GA .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (10) :1133-1138
[10]   Depression and C-reactive protein in US adults - Data from the Third National Health and Nutrition Examination Survey [J].
Ford, DE ;
Erlinger, TP .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (09) :1010-1014